![]() |
市場調查報告書
商品編碼
2049403
預裝層析管柱市場報告:按類型、技術、應用、最終用途和地區分類(2026-2034 年)Prepacked Chromatography Columns Market Report by Type, Technique, Application, End-Use, and Region 2026-2034 |
||||||
2025年,全球預載層析管柱市場規模達23億美元。展望未來,IMARC Group預測,該市場在2026年至2034年間將以6.05%的複合年成長率成長,到2034年達到40億美元。各種慢性疾病的日益普遍、疾病管理領域對生物製藥需求的成長以及層析法在各行業的廣泛應用是推動市場成長的關鍵因素。
生物製藥需求增加
包括癌症、糖尿病、心血管疾病和自體免疫疾病在內的各種慢性疾病盛行率不斷上升,正在推動市場成長。此外,對用於疾病管理的生物製藥的需求不斷成長也促進了市場成長。根據美國國立衛生研究院 (NIH) 估計,2022 年印度新增癌症病例數為 1,461,427 例(粗發病率為每 10 萬人 100.4 例)。在兒童(0-14 歲)癌症中,淋巴球白血病(男孩:29.2%,女孩:24.2%)是最常見的癌症類型。預計 2025 年新增癌症病例數將比 2020 年增加 12.8%。例如,根據國際糖尿病聯盟 (IDF) 發布的《糖尿病地圖集》(2021 年),10.5% 的成年人口(20-79 歲)患有糖尿病,其中近一半人對此毫不知情。根據國際糖尿病聯盟(IDF)的預測,到2045年,八分之一的成年人(約7.83億人)將患有糖尿病,增幅達46%。這將對預裝層析管柱市場的數據產生重大影響。
層析法技術的重大進步
此外,層析法技術的持續進步也正在推動市場成長。例如,高效液相層析(HPLC) 和親和層析法等層析法技術的不斷創新,提高了分離效率、速度和解析度。層析法在環境檢測中日益普及,也影響市場成長。例如,2023 年 6 月,安捷倫科技公司發表了兩款新型液相層析法質譜聯用 (LCMS) 系統,分別是 Agilent 6495D LC/TQ 和 Agilent Revident LC/Q-TQF。為了進一步提升 Revident LC/Q-TQF 的效能,安捷倫也發表了全新的 Agilent MassHunter Explorer 分析軟體和 Agilent ChemVistra 庫管理軟體。預計這些舉措將在未來幾年推動預裝層析管柱市場的成長。
人們越來越關注生物製程和一次性技術
在生物製藥和生物技術產業,人們越來越關注旨在提高生產效率和降低交叉污染風險的一次性技術,這推動了市場成長。一次性預注管柱無需批間清洗和驗證流程,從而最佳化了寶貴的生產時間,實現了更有效率、更經濟的生產。例如,2023年9月,專注於生物製程技術領先地位的生命科學公司Repligen Corporation宣布,已達成最終協議,收購總部位於瑞典莫恩達爾的私人公司Metenova AB(簡稱Metenova)。憑藉其磁力攪拌和驅動系統技術的成功(這些技術已被全球生物製藥公司和合約開發與生產組織 (CDMO) 廣泛採用),Metenova 預計 2023 年的銷售額將達到 2,400 萬至 2,500 萬美元。該公司最近推出了 MixOne 平台,進軍一次性攪拌市場,並充分利用了其現有不銹鋼(可重複使用)產品線的成功經驗。
The global prepacked chromatography columns market size reached USD 2.3 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 4.0 Billion by 2034, exhibiting a growth rate (CAGR) of 6.05% during 2026-2034.The growing prevalence of various chronic diseases, the rising demand for biopharmaceuticals for disease management, and increasing utilization of chromatography across various industries are some of the major factors propelling the growth of the market.
Increased Demand for Biopharmaceuticals
The rising prevalence of various chronic diseases including cancer, diabetes, cardiovascular disorders, and autoimmune conditions is driving the growth of the market. This, coupled with the escalating demand for biopharmaceuticals for disease management is strengthening the growth of the market. According to NIH, the estimated number of incident cases of cancer in India for the year 2022 was found to be 14,61,427 (crude rate:100.4 per 100000). Among the childhood (0-14 yr) cancers, lymphoid leukemia (boys: 29.2% and girls: 24.2%) was the leading site. The incidence of cancer cases is estimated to increase by 12.8% in 2025 as compared to 2020. For instance, IDF Diabetes Atlas (2021) reports that 10.5% of the adult population (20-79 years) has diabetes, with almost half unaware that they are living with the condition. By 2045, IDF projections show that one in eight adults approximately 783 million, will be living with diabetes an increase of 46%. This is infleuncing the prepacked chromatography columns market statistics significantly.
Significant Technological Advancement in Chromatography
The market is also driven by continuous advancements in chromatography technology. For instance, ongoing innovations in chromatographic techniques including high-performance liquid chromatography (HPLC) and affinity chromatography are improving the efficiency, speed, and resolution of separation. The widespread adoption of chromatography in environmental testing is influencing the growth of the market. For instance, in June 2023, Agilent Technologies Inc. announced two new liquid chromatography-mass spectrometry systems (LCMS), the Agilent 6495D LC/TQ and the Agilent Revident LC/Q-TQF. Facilitating the high-end performance of the Revident LC/Q-TQF, Agilent is also announcing the new Agilent MassHunter Explorer Profiling software and the new Agilent ChemVistra library manager software. This is expected to fuel the prepacked chromatography columns market forecast over the coming years.
Rising Emphasis on Bioprocessing and Single-Use Technologies
The increasing focus of biopharmaceutical and biotechnology industries towards single-use technologies to streamline production and reduce cross-contamination risk is contributing to the growth of the market. Single-use prepackaged columns optimize the use of valuable production time by eliminating the need for cleaning and validation steps between batches which leads to more efficient and cost-effective manufacturing. For instance, in September 2023, Repligen Corporation, a life sciences company focused on bioprocessing technology leadership, announced that it has entered into a definitive agreement to acquire privately held Metenova AB (Metenova) of Molndal, Sweden. Metenova is projected to generate revenues of $24 million to $25 million for fiscal year 2023, led by the success of its magnetic mixing and drive train technologies that are widely used by global biopharmaceutical companies and contract development and manufacturing organizations (CDMOs). The company recently entered the single-use mixing market with the launch of its MixOne platform, leveraging the success of its existing stainless steel (repeat-use) product line.
The publisher provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2026-2034. Our report has categorized the market based on type, technique, application, and end-use.
>1000 ML accounts for the majority of the market share
The rising preference for large column sizes across different industry verticals is driving the market segment. >1000 ML prepacked columns are commonly employed for the purification of biomolecules such as monoclonal antibodies, proteins, and vaccines. They facilitate high-capacity chromatographic separations, ensuring the production of pure and high-quality biopharmaceutical products. Additionally, food and beverage (F&B) manufacturers utilize >1000 mL prepacked columns for tasks like flavor extraction, quality control, and the separation of components like sugars, amino acids, and colorants. These columns aid in achieving consistent product quality and compliance with food safety regulations. In chemical research and development (R&D), these columns are essential for synthesizing and purifying compounds. Researchers can scale up their chromatographic processes efficiently, saving time and resources while ensuring product purity.
Ion-exchange chromatography holds the majority of the market share
Ion-exchange chromatography is versatile and can be applied to a wide range of biomolecules, including proteins, nucleic acids, and other charged molecules. This adaptability makes it suitable for various research and industrial applications. Additionally, it offers excellent selectivity based on the charge of the molecules being separated. By using ion-exchange resins with different functional groups, researchers can effectively separate and purify target molecules from complex mixtures. Apart from this, it provides high-resolution separation, enabling the isolation of closely related species with different charge properties. Furthermore, it can be easily scaled up for industrial production, making it suitable for large-scale purification processes in biopharmaceuticals, food processing, and other industries.
Sample preparation represents the largest market segment
Sample preparation is a fundamental prerequisite for chromatographic analyses which is fueling the segment growth in the market. It involves the extraction, clean-up, and concentration of target molecules from complex samples, ensuring that only relevant compounds reach the chromatography columns. The quality of sample preparation directly influences the accuracy and sensitivity of subsequent chromatographic analyses, making it an essential step. Additionally, diverse industries, including pharmaceuticals, biotechnology, food and beverage, environmental monitoring, and healthcare, heavily rely on chromatography for quality control, research, and product development. Furthermore, ongoing advancements in analytical techniques, such as high-performance liquid chromatography (HPLC) and mass spectrometry (MS), demand sample preparation methods that can cater to evolving needs.
Pharmaceutical and biotechnology companies account for the largest market share
Pharmaceutical and biotechnology companies are subject to rigorous regulatory requirements to ensure the safety and efficacy of their products which is further driving the segment growth in the market. Chromatography is a trusted and standardized method for characterizing and purifying compounds, making prepacked columns an attractive option for achieving compliance and maintaining consistency in manufacturing. Moreover, the continuous advancements in biopharmaceuticals, including monoclonal antibodies and gene therapies, have led to increased demand for specialized chromatography columns tailored to these complex molecules. Furthermore, these industries rely on precise and efficient separation and purification of biomolecules, such as proteins, antibodies, and nucleic acids, at various stages of drug development, production, and quality control. Prepacked chromatography columns offer ready-to-use solutions that significantly streamline these processes, reducing time and labor costs.
North America leads the market, accounting for the largest prepacked chromatography columns market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for prepacked chromatography columns.
North America is home to numerous pharmaceutical and biotechnology companies engaged in drug discovery, development, and production which is driving the market growth. Additionally, pharmaceutical and biotechnology sectors in North America are subject to strict regulatory standards set by the U.S. Food and Drug Administration (FDA) and Health Canada. Apart from this, several major players in the chromatography column manufacturing industry are headquartered or have a significant presence in North America. This concentration of key industry players fosters competition, innovation, and a wide range of product offerings. Furthermore, the region boasts advanced healthcare infrastructure, including cutting-edge diagnostic laboratories and healthcare facilities. Chromatography is extensively used in clinical diagnostics and research, further fueling the demand for prepacked columns. For instance, in February 2024, Shimadzu Corporation acquired the catalytic micro-reactive business for gas chromatography (GC) from Activated Research Company, LLC (ARC, Minnesota, USA).
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)